Charlotte's Web Q1 FY23 Revenue Declines 12.1% YoY, What About Net Loss?

Zinger Key Points
  • Adjusted EBITDA loss of $3.3 million, an improvement of $2.0 million compared to Q1 2022.
  • Gross profit was $9.9 million compared to gross profit of $11.8 million in Q1 2022.

Charlotte's Web Holdings, Inc. CWBHF CWEB net revenue for the first quarter ended March 31, 2023, was $17.0 million, a decrease of 12.1% from $19.4 million in the first quarter of 2022. The decrease was primarily due to lower oil tincture sales volume and related product mix for the periods.

Q1 2023 Financial Highlights

  • Gross profit was $9.9 million, or 58.3% of revenue, as compared to gross profit of $11.8 million, or 60.5% of revenue, in the first quarter of 2022.

  • Net loss for the first quarter was $2.9 million, or ($0.02) per share on a basic and diluted basis, as compared to a net loss of $8.6 million, or ($0.06) per share, on a basic and diluted basis in Q1 2022.

  • Adjusted EBITDA loss for the first quarter of 2023 was $3.3 million, an improvement of $2.0 million, or 57.7% as compared to an adjusted EBITDA loss of $5.3 million for the first quarter of 2022.

"In the first quarter, we maintained prudent cost controls to balance softness in the CBD category due to the unregulated environment. We successfully reduced operating expenses by 14% on a year-over-year basis and ended the first quarter with a cash balance of $61 million. This provides ample working capital to support growth plans, including the launch of ReCreate, our new NSF Certified for Sport lifestyle brand," stated Jessica Saxton, CFO. "We continue to maintain healthy gross profit margins and have improved our operating margins, despite a net revenue decline of 12.1% year-over-year."

Balance Sheet and Cash Flow
Net cash used from operations, for the three months ended March 31, 2023, was $6.1 million as compared to $4.7 million in Q1 2022. The first quarter of 2023 included rights fee payments to MLB which did not occur in the prior year period.

The company's cash and working capital as of March 31, 2023, were $60.8 million and $78.5 million respectively, compared to $67.0 million and $82.3 million at December 31, 2022, respectively.

Photo by Tim Foster on Unsplash

Related News

Exclusive: Cannabis And Lion's Mane-Infused Social Tonic BRĒZ Launches Across 33 States On 4/20

Snoop Dogg Praises NBA Cannabis Testing Policy Change: 'I Thought Of The Medical Side Of It'

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: CannabisEarningsNewsPenny StocksMarketsJessica Saxtonpremium
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Cannabis is evolving – don’t get left behind!

Curious about what’s next for the industry and how to leverage California’s unique market?

Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!

Get your tickets now to secure your spot and avoid last-minute price hikes.